Universal Definition of Loss to Follow-Up in HIV Treatment Programs: A Statistical Analysis of 111 Facilities in Africa, Asia, and Latin America
Background:
Although patient attrition is recognized as a threat to the long-term success of antiretroviral therapy programs worldwide, there is no universal definition for classifying patients as lost to follow-up (LTFU). We analyzed data from health facilities across Africa, Asia, and Latin America to empirically determine a standard LTFU definition.
Methods and Findings:
At a set “status classification” date, patients were categorized as either “active” or “LTFU” according to different intervals from time of last clinic encounter. For each threshold, we looked forward 365 d to assess the performance and accuracy of this initial classification. The best-performing definition for LTFU had the lowest proportion of patients misclassified as active or LTFU. Observational data from 111 health facilities—representing 180,718 patients from 19 countries—were included in this study. In the primary analysis, for which data from all facilities were pooled, an interval of 180 d (95% confidence interval [CI]: 173–181 d) since last patient encounter resulted in the fewest misclassifications (7.7%, 95% CI: 7.6%–7.8%). A secondary analysis that gave equal weight to cohorts and to regions generated a similar result (175 d); however, an alternate approach that used inverse weighting for cohorts based on variance and equal weighting for regions produced a slightly lower summary measure (150 d). When examined at the facility level, the best-performing definition varied from 58 to 383 d (mean = 150 d), but when a standard definition of 180 d was applied to each facility, only slight increases in misclassification (mean = 1.2%, 95% CI: 1.0%–1.5%) were observed. Using this definition, the proportion of patients classified as LTFU by facility ranged from 3.1% to 45.1% (mean = 19.9%, 95% CI: 19.1%–21.7%).
Conclusions:
Based on this evaluation, we recommend the adoption of ≥180 d since the last clinic visit as a standard LTFU definition. Such standardization is an important step to understanding the reasons that underlie patient attrition and establishing more reliable and comparable program evaluation worldwide.
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Universal Definition of Loss to Follow-Up in HIV Treatment Programs: A Statistical Analysis of 111 Facilities in Africa, Asia, and Latin America. PLoS Med 8(10): e32767. doi:10.1371/journal.pmed.1001111
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001111
Souhrn
Background:
Although patient attrition is recognized as a threat to the long-term success of antiretroviral therapy programs worldwide, there is no universal definition for classifying patients as lost to follow-up (LTFU). We analyzed data from health facilities across Africa, Asia, and Latin America to empirically determine a standard LTFU definition.
Methods and Findings:
At a set “status classification” date, patients were categorized as either “active” or “LTFU” according to different intervals from time of last clinic encounter. For each threshold, we looked forward 365 d to assess the performance and accuracy of this initial classification. The best-performing definition for LTFU had the lowest proportion of patients misclassified as active or LTFU. Observational data from 111 health facilities—representing 180,718 patients from 19 countries—were included in this study. In the primary analysis, for which data from all facilities were pooled, an interval of 180 d (95% confidence interval [CI]: 173–181 d) since last patient encounter resulted in the fewest misclassifications (7.7%, 95% CI: 7.6%–7.8%). A secondary analysis that gave equal weight to cohorts and to regions generated a similar result (175 d); however, an alternate approach that used inverse weighting for cohorts based on variance and equal weighting for regions produced a slightly lower summary measure (150 d). When examined at the facility level, the best-performing definition varied from 58 to 383 d (mean = 150 d), but when a standard definition of 180 d was applied to each facility, only slight increases in misclassification (mean = 1.2%, 95% CI: 1.0%–1.5%) were observed. Using this definition, the proportion of patients classified as LTFU by facility ranged from 3.1% to 45.1% (mean = 19.9%, 95% CI: 19.1%–21.7%).
Conclusions:
Based on this evaluation, we recommend the adoption of ≥180 d since the last clinic visit as a standard LTFU definition. Such standardization is an important step to understanding the reasons that underlie patient attrition and establishing more reliable and comparable program evaluation worldwide.
: Please see later in the article for the Editors' Summary
Zdroje
1. Joint United Nations Programme on HIV/AIDS 2009 Towards universal access: scaling up priority HIV/AIDS interventions in the health sector, progress report 2009 Geneva World Health Organization
2. World Health Organization 2006 Progress on global access to HIV antiretroviral therapy: a report on “3 by 5” and beyond, March 2006 Geneva World Health Organization
3. RosenSFoxMPGillCJ 2007 Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 4 e298 doi:10.1371/journal.pmed.0040298
4. FoxMPRosenS 2010 Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review. Trop Med Int Health 15 Suppl 1 1 15
5. EkoueviDKBalestreEBa-GomisFOEholieSPMaigaM 2010 Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa. Trop Med Int Health 15 Suppl 1 34 42
6. McGowanCCCahnPGotuzzoEPadgettDPapeJW 2007 Cohort profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol 36 969 976
7. DabisFBalestreEBraitsteinPMiottiPBrinkhofWG 2005 Cohort profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts. Int J Epidemiol 34 979 986
8. ChiBHCantrellRAMwangoAWestfallAOMutaleW 2010 An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs. Am J Epidemiol 171 924 931
9. StringerJSZuluILevyJStringerEMMwangoA 2006 Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296 782 793
10. Bolton-MooreCMubiana-MbeweMCantrellRAChintuNStringerEM 2007 Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA 298 1888 1899
11. International Epidemiologic Databases to Evaluate AIDS 2011 Participating regions. International Epidemiologic Databases to Evaluate AIDS. Available: http://www.iedea.org/regions. Accessed 23 September 2011
12. GengEHNashDKambuguAZhangYBraitsteinP 2010 Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep 7 234 244
13. BrinkhofMWDabisFMyerLBangsbergDRBoulleA 2008 Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 86 559 567
14. GengEHEmenyonuNBwanaMBGliddenDVMartinJN 2008 Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA 300 506 507
15. CesarCShepherdBEKrolewieckiAJFinkVISchechterM 2010 Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America. PLoS ONE 5 e10490 doi:10.1371/journal.pone.0010490
16. Wools-KaloustianKKimaiyoSMusickBSidleJSiikaA 2009 The impact of the President's Emergency Plan for AIDS Relief on expansion of HIV care services for adult patients in western Kenya. AIDS 23 195 201
17. Wools-KaloustianKKimaiyoSDieroLSiikaASidleJ 2006 Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. AIDS 20 41 48
18. BraitsteinPBrinkhofMWDabisFSchechterMBoulleA 2006 Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367 817 824
19. TuboiSHSchechterMMcGowanCCCesarCKrolewieckiA 2009 Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean. J Acquir Immune Defic Syndr 51 615 623
20. FalsterKChoiJYDonovanBDuncombeCMulhallB 2009 AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment. AIDS 23 2323 2336
21. LarsonBABrennanAMcNamaraLLongLRosenS 2010 Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health 15 Suppl 1 43 47
22. McGuireMMunyenyembeTSzumilinEHeinzelmannALe PaihM 2010 Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Trop Med Int Health 15 Suppl 1 55 62
23. HolmesCBWilliams-SherlockMABoueyPD 2009 Monitoring and evaluation of PEPFAR treatment programmes. Lancet 374 1146 1147
24. Zambian Ministry of Health 2010 Adult and adolescent antiretroviral therapy protocols Lusaka (Zambia) Printech Press
25. BrinkhofMWPujades-RodriguezMEggerM 2009 Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE 4 e5790 doi:10.1371/journal.pone.0005790
26. YiannoutsosCTAnMWFrangakisCEMusickBSBraitsteinP 2008 Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS ONE 3 e3843 doi:10.1371/journal.pone.0003843
27. EggerMSpycherBDSidleJWeigelRGengEH 2011 Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-saharan Africa. PLoS Med 8 e1000390 doi:10.1371/journal.pmed.1000390
28. LesterRTRitvoPMillsEJKaririAKaranjaS 2010 Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 376 1838 1845
29. BehforouzHLFarmerPEMukherjeeJS 2004 From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston. Clin Infect Dis 38 Suppl 5 S429 S436
30. KrebsDWChiBHMulengaYMorrisMCantrellRA 2008 Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care 20 311 317
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 10
- Mobilní aplikace jako nová možnost v prevenci napadení klíštětem
- Hydroresponzivní krytí v epitelizační fázi hojení rány
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Myasthenia gravis: kombinace chirurgie a farmakoterapie jako nejefektivnější modalita?
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME): An Extension of the STROBE Statement
- Universal Definition of Loss to Follow-Up in HIV Treatment Programs: A Statistical Analysis of 111 Facilities in Africa, Asia, and Latin America
- The Effect of Chromosome 9p21 Variants on Cardiovascular Disease May Be Modified by Dietary Intake: Evidence from a Case/Control and a Prospective Study
- Measuring the Performance of Vaccination Programs Using Cross-Sectional Surveys: A Likelihood Framework and Retrospective Analysis